middle.news
Bod Science Posts $51k Cash Inflow Amid Ongoing DOCA and Biortica Deal
7:03pm on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Bod Science Posts $51k Cash Inflow Amid Ongoing DOCA and Biortica Deal
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Net cash inflow from operating activities of $51k in Q2 FY2025
Customer receipts rose 14% quarter-on-quarter to $219k
Sale of intellectual property assets generated $125k proceeds
Company remains suspended under DOCA with administration ongoing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BOD
OPEN ARTICLE